1. Home
  2. KYMR vs BC Comparison

KYMR vs BC Comparison

Compare KYMR & BC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • BC
  • Stock Information
  • Founded
  • KYMR 2015
  • BC 1845
  • Country
  • KYMR United States
  • BC United States
  • Employees
  • KYMR N/A
  • BC N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • BC Homebuilding
  • Sector
  • KYMR Health Care
  • BC Consumer Discretionary
  • Exchange
  • KYMR Nasdaq
  • BC Nasdaq
  • Market Cap
  • KYMR 4.3B
  • BC 4.6B
  • IPO Year
  • KYMR 2020
  • BC N/A
  • Fundamental
  • Price
  • KYMR $63.94
  • BC $65.44
  • Analyst Decision
  • KYMR Strong Buy
  • BC Buy
  • Analyst Count
  • KYMR 19
  • BC 13
  • Target Price
  • KYMR $68.95
  • BC $67.92
  • AVG Volume (30 Days)
  • KYMR 665.0K
  • BC 871.0K
  • Earning Date
  • KYMR 11-04-2025
  • BC 10-23-2025
  • Dividend Yield
  • KYMR N/A
  • BC 2.63%
  • EPS Growth
  • KYMR N/A
  • BC N/A
  • EPS
  • KYMR N/A
  • BC N/A
  • Revenue
  • KYMR $43,735,000.00
  • BC $5,183,900,000.00
  • Revenue This Year
  • KYMR $60.88
  • BC $2.88
  • Revenue Next Year
  • KYMR N/A
  • BC $5.48
  • P/E Ratio
  • KYMR N/A
  • BC N/A
  • Revenue Growth
  • KYMR N/A
  • BC N/A
  • 52 Week Low
  • KYMR $19.45
  • BC $41.00
  • 52 Week High
  • KYMR $65.69
  • BC $87.65
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 63.12
  • BC 49.79
  • Support Level
  • KYMR $56.75
  • BC $63.82
  • Resistance Level
  • KYMR $61.21
  • BC $66.89
  • Average True Range (ATR)
  • KYMR 3.12
  • BC 2.05
  • MACD
  • KYMR -0.01
  • BC -0.38
  • Stochastic Oscillator
  • KYMR 83.30
  • BC 17.62

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About BC Brunswick Corporation

Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns more than 400 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.

Share on Social Networks: